PN vs. HA Filler: Different Goal, Different Result

A Basic Distinction

One of the most common mistakes I see in the clinic is the assumption that PN and filler are variations of the same thing. "They're both facial injections, so what's the difference?" — the difference is fundamental, and if you don't understand it, the expectations won't line up.

Hyaluronic acid (HA) filler is a material with physical volume. When it's injected, it takes up space. It changes shadows, lifts structures, fills cavities. This is mechanical-immediate work. The result is visible the same day, because the volume is already there.

Polynucleotides (PN) work entirely differently. They don't "fill" anything in the physical sense. They act on the cellular environment — influencing how fibroblasts function, the quality of the ECM (extracellular matrix), the repair processes in the tissue. It's a biological process that takes time, and its result is improved skin quality — not a change in shape or volume.

Mechanism of Action: Why It Matters

What PN Does in the Tissue

Polynucleotides are short chains of nucleotides derived from a biological source (usually purified salmon DNA). When injected into the dermis, they provide "signals" to local cells — primarily fibroblasts. These signals encourage repair activity: production of ECM components, improved internal hydration of the tissue, and reduced breakdown.

This doesn't happen in a day. Fibroblasts need to respond, produce, and organize. The process is gradual — weeks to months — and that's precisely the point. What improves is texture, thickness, elasticity, skin quality as a whole. Not shape.

What HA Filler Does

Cross-linked hyaluronic acid is a gel that stays at the injection site and occupies volume. It works on a simple mechanical principle: there's a cavity or lack of support — the filler fills it. This changes the map of facial shadows, restores structural support in areas that have lost volume (cheeks, jawline, lips), and creates a change visible immediately.

Filler doesn't improve skin quality itself. It doesn't make fibroblasts work better, doesn't thicken the dermis, doesn't change the state of the tissue. It's simply there — and over time the body breaks it down (usually within 6 to 18 months, depending on the product and area).

Clinical Comparison

In this table, I'm being explicit: PN won't replace filler, and filler won't replace PN. Any attempt to "substitute" one for the other will create wrong expectations.

When Each Is Appropriate

PN Fits When the Problem Is Quality

A patient who complains of "tired," thin, lackluster skin with uneven texture — and doesn't have missing facial volume — that's exactly where PN fits. The problem isn't in the shape but in the tissue's condition. There's nothing to "fill," there's something to improve.

Also in areas like under the eyes, where the skin is especially thin: sometimes what looks like "hollows" is actually skin so thin that it reveals what lies beneath. There, a quality-focused thickening of the dermis can change the appearance — without touching volume at all.

Filler Fits When the Problem Is Structural

When there's clear volume loss — sunken cheeks, a jawline losing definition, temples — mechanical support is needed. PN won't restore absorbed volume. If the dominant issue is structural change, the approach has to start with structure.

And here I need to be honest: there are situations in which even filler isn't enough. When volume loss is significant, when there's severe tissue laxity, or when the skeletal structure has changed (bone resorption) — the right intervention may be surgical. Not every problem is solvable with an injection.

Combination: When It Makes Sense

There are cases where both are relevant. For example: a patient with moderate cheek volume loss and also a decline in skin quality in the area. There you can combine — filler for structural support, PN to improve surrounding tissue quality. But the combination needs to be based on diagnosis, not a "default." Not every patient needs both, and sometimes one approach alone gives the best result.

The Common Mistake: Expecting PN to Fill Like Filler

I see it again and again: patients who come in after PN and complain that they "can't see a difference" — because they expected a volumetric change. They were looking for a change in shadows, in contour, in the shape of the face. PN doesn't do that. It isn't supposed to do that.

What it does do — improving texture, a thin thickening of the dermis, reducing the "tired look" — is sometimes less dramatic in the eyes of a patient who expected a change in shape. This isn't a failure of the treatment; it's a mismatch in expectations. And that's why this distinction is so important before starting.

On the other side, there's also the opposite assumption: that filler "improves skin quality." HA is indeed a molecule related to hydration, but cross-linked filler is not designed to improve fibroblast function or the state of the ECM. It simply sits there as volume. If a patient needs tissue quality improvement and receives filler — they'll get volume they didn't ask for, and they won't achieve the improvement they were looking for.

The Framework: Movement, Quality, Structure

We work with a framework that divides what affects facial appearance into three axes: movement (muscles, expressions), quality (tissue condition, texture, thickness), and structure (volume, skeletal support, tissue position).

PN belongs to the quality axis. Filler belongs to the structure axis. A neuromodulator belongs to the movement axis. When the diagnosis is clear, the choice is clear. When axes get mixed — for example, trying to solve a quality problem with a structural tool — the result is disappointing.

The right tool depends on the dominant problem. Sometimes only one axis needs to be treated. Sometimes two. But always — the diagnosis comes before the choice of tool.

Frequently Asked Questions